Restatement of Previously Issued Financial Statements - Consolidated Statements of Operations (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						6 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Jun. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Consolidated Statements of Operations
Revenues	$ 39,783	$ 33,121	$ 40,563	$ 33,988	$ 38,459	$ 42,154	$ 72,904	$ 80,613	$ 114,409	$ 114,601	$ 158,236	$ 155,164	$ 155,011
Cost of revenues	28,720	26,135	27,547	25,579	29,496	31,941	54,855	61,437	85,594	87,016	113,016	114,563	112,018
Gross margin	11,063	6,986	13,016	8,409	8,963	10,213	18,049	19,176	28,815	27,585	45,220	40,601	42,993
Operating expenses:
Selling, general and administrative	23,364	16,948	18,232	15,533	16,930	20,362	40,312	37,292	57,797	52,825	80,040	71,057	84,775
Research and development	3,565	1,144	2,031	(349)	2,225	1,128	4,709	3,353	8,529	3,004	10,863	5,035	8,393
Restructuring charges	457	860	42	0	25	755	1,317	780	1,317	780	1,287	822	4,203
Transaction expenses	347	1,103	1,284	1,437	0	0	1,450	0	1,450	1,437	1,450	2,721	2,605
Goodwill impairment	0	85,000	0	0	0	0	85,000	0	85,000	0	85,000	0	53,544
Operating loss	(16,670)	(98,069)	(8,573)	(8,212)	(10,217)	(12,032)	(114,739)	(22,249)	(125,278)	(30,461)	(133,420)	(39,034)	(110,527)
Interest expense	6,452	6,385	6,340	6,267	6,186	6,084	12,837	12,270	19,389	18,537	25,647	24,877	24,092
Net increase (decrease) in fair value of derivatives	(8,081)	23,807	9,188	(17,269)	2,430	13,012	15,726	15,442	14,396	(1,827)	107,658	7,361	(21,387)
Other (income) expense	(617)	(455)	(306)	(87)	0	0	(1,072)	0	(1,719)	(87)	(2,194)	(393)	19
Loss before taxes	(14,424)	(127,806)	(23,795)	2,877	(18,833)	(31,128)	(142,230)	(49,961)	(157,344)	(47,084)	(295,803)	(70,879)	(113,251)
Income tax benefit	15	(14)	(273)	(5)	(3)	59	1	56	22	51	(256)	(222)	(1,884)
Net loss	$ (14,439)	$ (127,792)	$ (23,522)	$ 2,882	$ (18,830)	$ (31,187)	$ (142,231)	$ (50,017)	$ (157,366)	$ (47,135)	$ (295,547)	$ (70,657)	$ (111,367)
Basic net loss per share (in usd per share)	$ (0.06)	$ (0.68)	$ (0.15)	$ 0.02	$ (0.13)	$ (0.23)	$ (0.66)	$ (0.35)	$ (0.69)	$ (0.32)	$ (1.27)	$ (0.47)	$ (0.87)
Diluted net loss per share (in usd per share)	$ (0.06)	$ (0.68)	$ (0.15)	$ 0.02	$ (0.13)	$ (0.23)	$ (0.66)	$ (0.35)	$ (0.69)	$ (0.32)	$ (1.27)	$ (0.47)	$ (0.87)
As previously reported
Consolidated Statements of Operations
Revenues	$ 39,783	$ 33,121	$ 40,563	$ 33,988	$ 38,459	$ 42,154	$ 72,904	$ 80,613	$ 114,409	$ 114,601		$ 155,164	$ 155,011
Cost of revenues	28,720	26,135	27,547	25,579	29,496	31,941	54,855	61,437	85,594	87,016		114,563	112,018
Gross margin	11,063	6,986	13,016	8,409	8,963	10,213	18,049	19,176	28,815	27,585		40,601	42,993
Operating expenses:
Selling, general and administrative	23,364	16,948	18,232	15,533	16,930	20,362	40,312	37,292	57,797	52,825		71,057	84,775
Research and development	3,565	1,144	2,031	(349)	2,225	1,128	4,709	3,353	8,529	3,004		5,035	8,393
Restructuring charges	457	860	42	0	25	755	1,317	780	1,317	780		822	4,203
Transaction expenses	347	1,103	1,284	1,437	0	0	1,450	0	1,450	1,437		2,721	2,605
Goodwill impairment	0	85,000	0	0	0	0	85,000	0	85,000	0		0	53,544
Operating loss	(16,670)	(98,069)	(8,573)	(8,212)	(10,217)	(12,032)	(114,739)	(22,249)	(125,278)	(30,461)		(39,034)	(110,527)
Interest expense	3,551	3,555	3,544	3,540	3,560	3,556	7,106	7,116	10,647	10,656		14,200	14,436
Net increase (decrease) in fair value of derivatives	(7,882)	23,992	9,395	(15,659)	3,121	10,567	16,110	13,688	14,832	(1,971)		7,424	(1,591)
Other (income) expense	(617)	(455)	(306)	(87)	0	0	(1,072)	0	(1,719)	(87)		(393)	19
Loss before taxes	(11,722)	(125,161)	(21,206)	3,994	(16,898)	(26,155)	(136,883)	(43,053)	(149,038)	(39,059)		(60,265)	(123,391)
Income tax benefit	15	(14)	50	(5)	(3)	59	1	56	22	51		101	(1,717)
Net loss	$ (11,737)	$ (125,147)	$ (21,256)	$ 3,999	$ (16,895)	$ (26,214)	$ (136,884)	$ (43,109)	$ (149,060)	$ (39,110)		$ (60,366)	$ (121,674)
Basic net loss per share (in usd per share)	$ (0.05)	$ (0.67)	$ (0.14)	$ 0.03	$ (0.12)	$ (0.19)	$ (0.63)	$ (0.30)	$ (0.65)	$ (0.27)		$ (0.40)	$ (0.95)
Diluted net loss per share (in usd per share)	$ (0.05)	$ (0.67)	$ (0.14)	$ 0.03	$ (0.12)	$ (0.19)	$ (0.63)	$ (0.30)	$ (0.65)	$ (0.27)		$ (0.40)	$ (0.95)
Restatement adjustment
Consolidated Statements of Operations
Revenues	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0		$ 0	$ 0
Cost of revenues	0	0	0	0	0	0	0	0	0	0		0	0
Gross margin	0	0	0	0	0	0	0	0	0	0		0	0
Operating expenses:
Selling, general and administrative	0	0	0	0	0	0	0	0	0	0		0	0
Research and development	0	0	0	0	0	0	0	0	0	0		0	0
Restructuring charges	0	0	0	0	0	0	0	0	0	0		0	0
Transaction expenses	0	0	0	0	0	0	0	0	0	0		0	0
Goodwill impairment	0	0	0	0	0	0	0	0	0	0		0	0
Operating loss	0	0	0	0	0	0	0	0	0	0		0	0
Interest expense	2,901	2,830	2,796	2,727	2,626	2,528	5,731	5,154	8,742	7,881		10,677	9,656
Net increase (decrease) in fair value of derivatives	(199)	(185)	(207)	(1,610)	(691)	2,445	(384)	1,754	(436)	144		(63)	(19,796)
Other (income) expense	0	0	0	0	0	0	0	0	0	0		0	0
Loss before taxes	(2,702)	(2,645)	(2,589)	(1,117)	(1,935)	(4,973)	(5,347)	(6,908)	(8,306)	(8,025)		(10,614)	10,140
Income tax benefit	0	0	(323)	0	0	0	0	0	0	0		(323)	(167)
Net loss	$ (2,702)	$ (2,645)	$ (2,266)	$ (1,117)	$ (1,935)	$ (4,973)	$ (5,347)	$ (6,908)	$ (8,306)	$ (8,025)		$ (10,291)	$ 10,307
Basic net loss per share (in usd per share)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.04)	$ (0.03)	$ (0.05)	$ (0.04)	$ (0.05)		$ (0.07)	$ 0.08
Diluted net loss per share (in usd per share)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.01)	$ (0.04)	$ (0.03)	$ (0.05)	$ (0.04)	$ (0.05)		$ (0.07)	$ 0.08